Royalty Pharma (RPRX) Event Aug. 04, 2022, 00:00 UTC (70% Positive) Royalty Pharma plc (RPRX) Reports 43% Profit Growth for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 11:02 a.m. 🏢 Royalty Pharma (RPRX) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $509.89M $356.26M $153.63M +43.12% 📉 Total Assets $17.52B $17.74B $-224.55M -1.27% ↘️ Total Liabilities $7.27B $7.33B $-64.91M -0.89% ↘️ Operating Income/Loss $974.25M $597.51M $376.74M +63.05% 📉 R&D Expense $100.00M $5.80M $94.20M +1624.14% 📉 Revenues $1.13B $1.10B $29.99M +2.73% ➡️ Earningspersharebasic $1.28 $0.82 $0.46 +56.10% 📈 Earningspersharediluted $1.25 $0.82 $0.43 +52.44% 📈 📈 Financial Trend Analysis 💰 Profitability improved with +43.1% net income growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Royalty Pharma (RPRX) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
💰 Profitability improved with +43.1% net income growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document